
Journal Menu
► ▼ Journal Menu-
- Biomolecules Home
- Aims & Scope
- Editorial Board
- Reviewer Board
- Topical Advisory Panel
- Instructions for Authors
- Special Issues
- Topics
- Sections & Collections
- Article Processing Charge
- Indexing & Archiving
- Editor’s Choice Articles
- Most Cited & Viewed
- Journal Statistics
- Journal History
- Journal Awards
- Conferences
- Editorial Office
Journal Browser
► ▼ Journal BrowserNeed Help?
Announcements
7 September 2025
World Duchenne Awareness Day—“Family: The Heart of Care”, 7 September 2025

Duchenne muscular dystrophy is a condition that, while currently incurable, is the focus of extensive research aimed at prevention and treatment to improve the health and quality of life for those affected. Each year, we observe World Duchenne Awareness Day to enhance public understanding of the profound health, social, and economic impacts of Duchenne muscular dystrophy (DMD) and to bolster our efforts in combating this condition.
The day marks the birthday of Guillaume Duchenne, the physician who first described the disorder in the 19th century, thus setting the stage for advancements in diagnosis and care. It is our hope that esteemed journals in the fields of Biology, Life Sciences, and Medicine & Pharmacology at MDPI will continue to act as forums for the dissemination of cutting-edge research and innovative concepts related to the prevention and treatment of Duchenne muscular dystrophy.
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
“CRISPR/Cas9-Targeted Myostatin Deletion Improves the Myogenic Differentiation Parameters for Muscle-Derived Stem Cells in Mice”
by Mohamed I. Elashry, Victoria C. Schneider, Manuela Heimann, Sabine Wenisch and Stefan Arnhold
J. Dev. Biol. 2025, 13(1), 5; https://doi.org/10.3390/jdb13010005
“Evaluation of Creatine Monohydrate Supplementation on the Gastrocnemius Muscle of Mice with Muscular Dystrophy: A Preliminary Study”
by Victor Augusto Ramos Fernandes, Gabriela Pereira dos Santos, Amilton Iatecola, Daniela Vieira Buchaim, Ionaly Judith Faria Garcia, Carlos Henrique Bertoni Reis, Lívia Maluf Menegazzo Bueno, Bruna Trazzi Pagani, Rogerio Leone Buchaim and Marcelo Rodrigues da Cunha
Pathophysiology 2025, 32(1), 2; https://doi.org/10.3390/pathophysiology32010002
“Appendicular Skeletal Muscle Index Is Positively Related to Mediterranean Diet Adherence in University Students”
by Paraskevi Detopoulou, Olga Magni, Ioanna Pylarinou, Despoina Levidi, Vassilios Dedes, Milia Tzoutzou, Konstantina Argyri, Evangelia Fappa, Aristea Gioxari and George Panoutsopoulos
Diseases 2025, 13(1), 3; https://doi.org/10.3390/diseases13010003
“MRI-Based Circumferential Strain in Boys with Early Duchenne Muscular Dystrophy Cardiomyopathy”
by Zhan-Qiu Liu, Nyasha G. Maforo, Patrick Magrath, Ashley Prosper, Pierangelo Renella, Nancy Halnon, Holden H. Wu and Daniel B. Ennis
Diagnostics 2024, 14(23), 2673; https://doi.org/10.3390/diagnostics14232673
“An Updated Analysis of Exon-Skipping Applicability for Duchenne Muscular Dystrophy Using the UMD-DMD Database”
by Jamie Leckie, Abdullah Zia and Toshifumi Yokota
Genes 2024, 15(11), 1489; https://doi.org/10.3390/genes15111489
“A Comprehensive Workplace Exercise Intervention to Reduce Musculoskeletal Pain and Improve Functional Capacity in Office Workers: A Randomized Controlled Study”
by Konstantina Karatrantou and Vassilis Gerodimos
Healthcare 2024, 12(9), 915; https://doi.org/10.3390/healthcare12090915
“Evaluation of Neuromuscular Diseases and Complaints by Quantitative Muscle MRI”
by Lara Schlaffke, Robert Rehmann, Anne-Katrin Güttsches, Matthias Vorgerd, Christine H. Meyer-Frießem, Hubert R. Dinse, Elena Enax-Krumova, Martijn Froeling and Johannes Forsting
J. Clin. Med. 2024, 13(7), 1958; https://doi.org/10.3390/jcm13071958
“Nuclear Small Dystrophin Isoforms during Muscle Differentiation”
by Tina Donandt, Vanessa Todorow, Stefan Hintze, Alexandra Graupner, Benedikt Schoser, Maggie C. Walter and Peter Meinke
Life 2023, 13(6), 1367; https://doi.org/10.3390/life13061367
“Orphan Drugs in Neurology—A Narrative Review”
by Carmen Adella Sirbu, Raluca Ivan, Francois Jerome Authier, Florentina Ionita-Radu, Dragos Catalin Jianu, Octavian Vasiliu, Ciprian Constantin and Sorin Tuță
J. Pers. Med. 2023, 13(3), 420; https://doi.org/10.3390/jpm13030420
“Muscle Wasting, Aging, and Cancer: The Effects of Physical Exercise” Guest Editor: Prof. Dr. Paula Tavares Submission deadline: 28 November 2025 |
“Genetic Diagnosis and Treatment of Duchenne Muscular Dystrophy” Guest Editor: Dr. Liubov V. Gushchina Submission deadline: 20 December 2025 |
![]() |
![]() |
“Muscular Dystrophy: From Molecular Basis to Therapies: 2nd Edition” Guest Editor: Dr. Francesca Sciandra and Dr. Kinga I. Gawlik Submission deadline: 15 January 2026 |
“Dysfunctions or Approaches of the Musculoskeletal System” Guest Editors: Prof. Dr. Paloma Moro and Prof. Dr. Jorge Rodriguez Submission deadline: 28 February 2026 |
![]() |
![]() |
“Neuromuscular Diseases and Musculoskeletal Disorders” Guest Editor: Dr. Anna Christakou Submission deadline: 28 February 2026 |
“Mitochondrial Function and Dysfunction in Developmental Biology Metabolism” Guest Editor: Prof. Dr. Simon J. Conway Submission deadline: 15 March 2026 |
![]() |
![]() |
3 September 2025
Join Us at the MDPI at the University of Toronto Career Fair, 23 September 2025, Toronto, ON, Canada

Date: 23 September 2025
Time: 11:00 a.m.–4:30 p.m
Location: The Chelsea Hotel, 33 Gerrard Street West, Toronto
MDPI is thrilled to announce our participation in the University of Toronto’s largest career fair, taking place at the St. George Downtown Campus. This exciting event brings together thousands of students, graduates, and professionals looking to connect with top employers and explore career opportunities.
We invite all attendees to visit the MDPI booth to discover how you can be part of one of the world’s leading open access academic publishers. Whether you are passionate about scientific research, editorial work, marketing, or supporting global innovation in publishing, we want to meet YOU!
What to expect at our booth:
- Learn more about MDPI’s mission and global impact;
- Explore exciting career opportunities in publishing, editorial, communications, and more;
- Network with our team and ask questions about working at MDPI.
Whether you’re just starting your career or looking to take the next step, don’t miss this opportunity to connect with MDPI. Bring your resume, your curiosity, and your questions—we look forward to seeing you there!
For additional information on the Career Fair and Open MDPI positions, please visit the following links:
1 September 2025
MDPI INSIGHTS: The CEO’s Letter #26 – CUJS, Head of Ethics, Open Peer Review, AIS 2025, Reviewer Recognition

Welcome to the MDPI Insights: The CEO's Letter.
In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.
Opening Thoughts
Society of China University Journals (CUJS) visit to MDPI Basel
In August, we had the pleasure of welcoming a delegation from the Society of China University Journals (CUJS) to our Basel headquarters. The visit was part of CUJS’s broader European tour, which included meetings with several major publishing organizations.
Purpose of the visit
The delegation’s stop in Basel involved an introductory meeting and knowledge-sharing with a view to identifying potential collaboration opportunities with MDPI. The CUJS team shared an overview of the Chinese scientific publishing landscape, including recent policy developments, and gave us insights into the journals and services they operate across China’s academic institutions.
MDPI presentations
We used the opportunity to introduce CUJS to MDPI’s mission, structure, and recent achievements. I presented on the latest developments at MDPI and our role in supporting global open access, addressing many follow-up questions from the delegation. Warm thanks are due to the following colleagues for their contributions to the session:
- Liliane Auwerter (Conference Organizer, Scientific Officer and Sustainability Specialist) shared an overview of our editorial process, including the quality indicators we use to track peer-review performance.
- Renato Merki (Publication Ethics Assistant) presented on behalf of our Research Integrity and Ethics team, emphasizing our commitment to responsible publishing.
- Silvano Bonfatti (Product Manager) introduced the JAMS platform, highlighting how it supports efficient journal management for editors and publishers alike.
- Aimar Xiong (Publisher, Section Managing Editor) and Giuliano Braccini (Office Manager) facilitated the meeting, offering clarity in response to specific questions, building the relationship during and beyond the meeting itself.
“Building relationships with organizations such as CUJS allows us to increase our visibility and reputation”
Why is this important?
China is one of the world’s largest producers of scientific research, with its universities and research institutes playing a key role in global scholarly publishing. Building strong relationships with influential organizations such as CUJS allows us to increase our visibility and reputation vis-à-vis the Chinese academic community, share best practices, learn from differing publishing models, and explore collaborations that have the potential to enhance the quality, reach, and diversity of our journals.
Looking ahead
It was a productive and friendly exchange that reflected our shared commitment to advancing scholarly communication and improving journal publishing practices. We value these visits, which allow us to create collaborations with stakeholders in the global academic community.
Our Basel office is a hub for hosting international delegations, partners, and collaborators. We look forward to creating more global connections that support our mission.
Impactful Research
Appointment of Dr. Tim Tait-Jamieson as Head of Publication Ethics
As part of our ongoing commitment to research integrity and publishing excellence, I am delighted to announce that we have appointed Dr. Tim Tait-Jamieson as Head of Publication Ethics.
In this role, Tim will lead the development of our ethics strategy and oversee the continued growth of the Publication Ethics Department, which is based across our offices in Basel, Manchester, Belgrade/Novi Sad, and Cluj. Guided by the principles of effective prevention and efficient resolution, the department plays an essential role in ensuring the highest standards of integrity throughout our editorial processes.
Department focus
Working closely with internal teams and external partners, the Publication Ethics Department focuses on refining our policies, aligning our operations with international best practices, and addressing complex cases with fairness and transparency. This work is critical in supporting our editors, reviewers, and authors, reinforcing MDPI’s contribution to the global dialogue on research integrity.
“Research integrity is something to which we all contribute through our daily work at MDPI”
About Tim
Tim joined MDPI in 2021 and has held several roles within the Publication Ethics Department, most recently serving as Research Integrity Lead. Based in our Basel office, he brings a strong academic background, with a Ph.D. in Geography from the University of Fribourg, Switzerland, and a proven track record of leadership in research integrity.
Research integrity is something to which we all contribute through our daily work at MDPI. I look forward to Tim’s leadership as we continue investing in the people, processes, and partnerships that uphold the trust and credibility of scholarly publishing.
Read more:
Inside MDPI
How and why MDPI offers Open Peer Review
At MDPI, we are committed to advancing openness and transparency in scholarly publishing. One area where we’ve taken a leadership role is peer review. Since 2014, MDPI has offered authors the option of open peer review, giving them the opportunity to publish reviewer comments alongside their papers. Each year, more authors are choosing this path, helping to build trust in the editorial process and provide valuable context for the research we publish.
Jack McKenna (Senior Content Specialist, MDPI) recently wrote an informative piece looking at the impact and importance of open peer review at MDPI. He highlights how this approach not only benefits readers but also gives well-deserved recognition to our reviewers, who generously dedicate their time and expertise to the academic community.
I encourage you to read this blogpost to see how MDPI is helping set standards for transparency in scholarly publishing.
Coming Together for Science
Recap of MDPI’s AIS 2025 Conference in Kuala Lumpur
Entering the month of August, we held The 2nd International Conference on AI Sensors and Transducers (AIS 2025) in Kuala Lumpur, Malaysia.
“AIS is quickly becoming a premier event in the field”
The second edition of AIS brought together 335 attendees from across Asia and beyond, including participants from China, Japan, Korea, and Southeast Asia. The event, chaired by Prof. Dr. Toshihiro Itoh (University of Tokyo), Prof. Dr. Sang-Woo Kim (Yonsei University), and Prof. Dr. Chengkuo Lee (National University of Singapore), continues to grow in reputation and has become an important platform for researchers and students to present their work, exchange ideas, and build international collaborations.
AIS is quickly becoming a premier event in the field, with participants highlighting its quality of service, its expanding academic network, and the value it delivers in the context of tightening research budgets in the region.
It was also excellent to see our new MDPI journal AI Sensors, which originated from a conference topic, host a successful launch party at the event.
Highlights from participant feedback:
- Southeast University (China) sent a student delegation and considers AIS a regular fixture for Ph.D. students in need of international conference experience.
- CAS Aerospace Information Research Institute sent a 10-member delegation and plans to further promote AIS internally.
- Japanese researchers regard AIS as a must-attend event, placing it on a par with IEEE conferences and citing the benefits of networking and exchange.
- Korean academics praised the organization and noted improved perceptions of MDPI among their institutions, viewing AIS as a strategic opportunity to deepen engagement in the region.
Award winners
We recognized the recipients of the Best Presentation, Best Scientist, Best Poster, and Best Student Paper awards, whose contributions set a standard for academic excellence. The full award announcement is available here.
Looking ahead
The 3rd International Conference on AI Sensors and Transducers will be held from 5 to10 August 2026 in Jeju, Korea. The General Chairs will be Prof. Inkyu Park (Korea Advanced Institute of Science and Technology), Prof. Zhou Li (Tsinghua University), Prof. Xinge Yu (City University of Hong Kong), and Prof. Chengkuo Lee (National University of Singapore). We look forward to bringing together innovators, researchers and experts who are shaping the future at the intersection of sensors, sensing technology, transducers and artificial intelligence.
Thank you
Our conference team managed this event with great agility and professionalism and are already planning improvements to make the conference even more accessible. Special thanks to the National University of Singapore for their support, and to our entire conference team and collaborators for their dedication.
AIS is gaining momentum, and we look forward to supporting its role as a bridge between MDPI and the global academic community.
“Our conference team managed this event with great agility and professionalism”
Closing Thoughts
Recognizing our outstanding reviewers
As we close this edition of the newsletter, I would like to spotlight MDPI’s 2024 Outstanding Reviewer Awards, which showcase a group of winners whose contributions often go unseen but are essential to the integrity of scholarly publishing: our reviewers.
In 2024, more than 215,000 reviewers dedicated their time and expertise to MDPI journals. From this community, we are proud to recognize 356 recipients of the Outstanding Reviewer Awards, who went above and beyond by providing timely, thorough and constructive feedback.
These awards are not only a token of our appreciation but also a reflection of the values we stand for: rigor, fairness and collaboration in advancing science.
To explore the full list of awardees across disciplines, from life sciences to the humanities, please visit the following pages:
- Biology and Life Sciences
- Business and Economics
- Chemistry and Materials Science
- Computer Science and Mathematics
- Engineering
- Environmental and Earth Sciences
- Medicine and Pharmacology
- Physical Sciences
- Public Health and Healthcare
- Social Sciences, Arts and Humanities
About MDPI Awards
To recognize the academic community, MDPI journals regularly offer various awards to researchers in specific fields. Serving as a source of recognition and inspiration, these awards help increase the influence of scholars who have been credited with outstanding achievements and are making a significant contribution to the advancement of their respective fields.
To explore more opening Outstanding Reviewer Awards, please click here.
To all our reviewers: thank you for being the foundation of trust that makes open access publishing possible!
Chief Executive Officer
MDPI AG
1 September 2025
Meet Us at the 2025 International Conference of the Korean Society for Molecular and Cellular Biology (KSMCB 2025), 29 September–2 October 2025, Jeju Island, Republic of Korea

Conference: 2025 International Conference of the Korean Society for Molecular and Cellular Biology (KSMCB 2025)
Booth Number: 72
Date: 29 September–2 October 2025
Location: ICC Jeju, Jeju Island, Republic of Korea
The Korean Society for Brain and Neural Sciences (KSBNS) was founded in 1998 and has expanded to become one of the largest and most prominent academic societies in the field of life sciences in Korea. The KSMCB aims to advance research, communication, collaboration, and education in the field of biological sciences, from fundamental molecular biology to biomedical and agricultural research. The programs featured in the ICKSMCB offer a platform to cultivate bioscience research and disseminate scientific discoveries, cutting-edge information, and innovative ideas.
MDPI will be attending the 2025 International Conference of the KSMCB (ICKSMCB) as an exhibitor. This event will be held from 29 September to 2 October, and we welcome all researchers to visit our booth and discuss their latest research with us.
The following MDPI journals will be represented at the conference:
- Life;
- Sci;
- Biophysica;
- Cells;
- Biologics;
- BioMed;
- Biomedicines;
- Biomolecules;
- BioTech;
- Cancers;
- Current Issues in Molecular Biology;
- Genes;
- International Journal of Molecular Sciences;
- Metabolites;
- Microorganisms;
- Non-Coding RNA;
- Plants.
Our delegates look forward to meeting you in person at our booth and answering any questions you may have. For more information regarding this conference, please visit the following website: https://www.ksmcb.or.kr/icksmcb2025/main.html.
25 August 2025
Dr. Anthony S. Zannas Appointed Section Editor-in-Chief of Section “Molecular Biomarkers” in Biomolecules

We are pleased to announce that Dr. Anthony S. Zannas has been appointed Section Editor-in-Chief of the Section “Molecular Biomarkers” in Biomolecules (ISSN: 2218-273X).
The Section “Molecular Biomarkers”, part of MDPI’s open access journal Biomolecules publishes papers in all areas related to molecular biomarker research. This includes the identification, validation, and application of biomarkers in innovative diagnostic procedures, drug discovery/development, and disease pathogenesis.
We seek review and original research articles that address, but are not limited to, the following topics:
- Predictive biomarkers;
- Diagnostic biomarkers;
- Prognostic biomarkers;
- Pharmacokinetic and pharmacodynamic biomarkers;
- Optimum biomarker selection and validation;
- Biomarker development in omics;
- Biomarker development in molecular medicine.
Dr. Anthony S. Zannas is an Associate Professor and Co-Director of the Carolina Stress Initiative at the Departments of Psychiatry and Genetics, the University of North Carolina. His research interests pertain to epigenetic and other molecular mechanisms linking environmental stress with accelerated aging and disease risk.
The following is a short Q&A with Dr. Anthony S. Zannas, who has shared his vision for the journal with us, as well as his views on the research area and open access publishing:
1. What appealed to you about the journal that made you want to become its Section Editor-in-Chief?
Biomolecules, and MDPI journals more generally, provide an accessible and efficient way of disseminating quality research.
2. What is your vision for this Section?
It covers a critical and timely area of research. Molecular biomarkers are a key tool for the future of biomedical science.
3. What does the future of this field of research look like?
Many of us envision a day when we will have highly reliable biomarkers to apply precision medicine, such as predicting individuals who will develop distinct disease outcomes or those who will respond to specific treatments. Despite many technological advancements, however, there is still a lot of work that needs to be done to materialize this vision.
4. Do you have any suggestions for young researchers in this field?
I always encourage young investigators to persevere and pursue their dreams. Good research takes time, and I believe that perseverance through failures and frustrations is the most important quality of a successful researcher.
5. What do you think of the development of open access in the publishing field?
While there are pros and cons, open access is currently a widespread trend in the field of publication. We can continue working together to support peer-reviewed research that serves the scientific community.
We welcome Dr. Anthony S. Zannas as the Section Editor-in-Chief for “Molecular Biomarkers”, and we look forward to achieving many more milestones under his guidance.
18 August 2025
Biomolecules | Highly Cited Papers Published in 2024–2025 in the “Cellular Biochemistry” Section

As all of the articles published in our journal are open access, you have free and unlimited access to the full text. We welcome you to read our most highly cited papers published in 2024 and 2025, which are listed below:
1. “Extracellular Matrix Components and Mechanosensing Pathways in Health and Disease”
by Aikaterini Berdiaki, Monica Neagu, Petros Tzanakakis, Ioanna Spyridaki, Serge Pérez and Dragana Nikitovic
Biomolecules 2024, 14(9), 1186; https://doi.org/10.3390/biom14091186
Full text available online: https://www.mdpi.com/2218-273X/14/9/1186
2. “How Do ROS Induce NETosis? Oxidative DNA Damage, DNA Repair, and Chromatin Decondensation”
by Dhia Azzouz and Nades Palaniyar
Biomolecules 2024, 14(10), 1307; https://doi.org/10.3390/biom14101307
Full text available online: https://www.mdpi.com/2218-273X/14/10/1307
3. “Astrocytes: The Stars in Neurodegeneration?”
by Katarina Stoklund Dittlau and Kristine Freude
Biomolecules 2024, 14(3), 289; https://doi.org/10.3390/biom14030289
Full text available online: https://www.mdpi.com/2218-273X/14/3/289
4. “Factors and Mechanisms of Thyroid Hormone Activity in the Brain: Possible Role in Recovery and Protection”
by Laura Sabatino, Dominga Lapi and Cristina Del Seppia
Biomolecules 2024, 14(2), 198; https://doi.org/10.3390/biom14020198
Full text available online: https://www.mdpi.com/2218-273X/14/2/198
5. “Mitochondrial Dysfunction as the Major Basis of Brain Aging”
by Stephen C. Bondy
Biomolecules 2024, 14(4), 402; https://doi.org/10.3390/biom14040402
Full text available online: https://www.mdpi.com/2218-273X/14/4/402
6. “Space Flight Enhances Stress Pathways in Human Neural Stem Cells”
by Nicholas Carpo, Victoria Tran, Juan Carlos Biancotti, Carlos Cepeda and Araceli Espinosa-Jeffrey
Biomolecules 2024, 14(1), 65; https://doi.org/10.3390/biom14010065
Full text available online: https://www.mdpi.com/2218-273X/14/1/65
7. “Comparison between the Regenerative and Therapeutic Impacts of Bone Marrow Mesenchymal Stem Cells and Adipose Mesenchymal Stem Cells Pre-Treated with Melatonin on Liver Fibrosis”
by Ahmed Elzainy, Abir El Sadik and Waleed Mohammad Altowayan
Biomolecules 2024, 14(3), 297; https://doi.org/10.3390/biom14030297
Full text available online: https://www.mdpi.com/2218-273X/14/3/297
8. “Monogenic Disorders of ROS Production and the Primary Anti-Oxidative Defense”
by Nana-Maria Grüning and Markus Ralser
Biomolecules 2024, 14(2), 206; https://doi.org/10.3390/biom14020206
Full text available online: https://www.mdpi.com/2218-273X/14/2/206
9. “Quercetin: Molecular Insights into Its Biological Roles”
by Hye Joon Boo, Danbi Yoon, Yujeong Choi, Younghyun Kim, Jeong Seok Cha and Jiho Yoo
Biomolecules 2025, 15(3), 313; https://doi.org/10.3390/biom15030313
Full text available online: https://www.mdpi.com/2218-273X/15/3/313
10. “Autophagy and Cancer: Insights into Molecular Mechanisms and Therapeutic Approaches for Chronic Myeloid Leukemia”
by Mohd Adnan Kausar, Sadaf Anwar, Yusuf Saleem Khan, Ayman A. Saleh, Mai Ali Abdelfattah Ahmed, Simran Kaur, Naveed Iqbal, Waseem Ahmad Siddiqui and Mohammad Zeeshan Najm
Biomolecules 2025, 15(2), 215; https://doi.org/10.3390/biom15020215
Full text available online: https://www.mdpi.com/2218-273X/15/2/215
18 August 2025
Biomolecules | Highly Cited Papers Published in 2024–2025 in the “Biological Factors” Section

As all of the articles published in our journal are open access, you have free and unlimited access to the full text. We welcome you to read our most highly cited papers published in 2024 and 2025, which are listed below:
1. “The Ethylene Biosynthetic Enzymes, 1-Aminocyclopropane-1-Carboxylate (ACC) Synthase (ACS) and ACC Oxidase (ACO): The Less Explored Players in Abiotic Stress Tolerance”
by Sheen Khan, Ameena Fatima Alvi, Sadaf Saify, Noushina Iqbal and Nafees A. Khan
Biomolecules 2024, 14(1), 90; https://doi.org/10.3390/biom14010090
Full text available online: https://www.mdpi.com/2218-273X/14/1/90
2. “Placenta Extracellular Vesicles: Messengers Connecting Maternal and Fetal Systems”
by Cheryl S. Rosenfeld
Biomolecules 2024, 14(8), 995; https://doi.org/10.3390/biom14080995
Full text available online: https://www.mdpi.com/2218-273X/14/8/995
3. “From Cure to Crisis: Understanding the Evolution of Antibiotic-Resistant Bacteria in Human Microbiota”
by Hamed Tahmasebi, Neda Arjmand, Marzieh Monemi, Ali Babaeizad, Farnaz Alibabaei, Negar Alibabaei, Aisa Bahar, Valentyn Oksenych and Majid Eslami
Biomolecules 2025, 15(1), 93; https://doi.org/10.3390/biom15010093
Full text available online: https://www.mdpi.com/2218-273X/15/1/93
4. “Activation of Cannabinoid Type 2 Receptor in Microglia Reduces Neuroinflammation through Inhibiting Aerobic Glycolysis to Relieve Hypertension”
by Ruohan Shan, Yuxiang Zhang, Yiping Shi, Xiaowen Wang, Xueke Wang, Guanying Ma and Qian Li
Biomolecules 2024, 14(3), 333; https://doi.org/10.3390/biom14030333
Full text available online: https://www.mdpi.com/2218-273X/14/3/333
5. “Mesenchymal Stem Cell-Derived Exosomes: Emerging as a Promising Cell-Free Therapeutic Strategy for Autoimmune Hepatitis”
by Liwen Wu, Longze Zhang, Minglei Huang, Yan Wu, Sikan Jin, Yaqi Zhang, Xinyun Gan, Ting Yu, Guang Yu, Jidong Zhang and Xianyao Wang
Biomolecules 2024, 14(11), 1353; https://doi.org/10.3390/biom14111353
Full text available online: https://www.mdpi.com/2218-273X/14/11/1353
6. “From Polydeoxyribonucleotides (PDRNs) to Polynucleotides (PNs): Bridging the Gap Between Scientific Definitions, Molecular Insights, and Clinical Applications of Multifunctional Biomolecules”
by Cíntia Marques, Alexandre Porcello, Marco Cerrano, Farid Hadjab, Michèle Chemali, Kelly Lourenço, Basste Hadjab, Wassim Raffoul, Lee Ann Applegate and Alexis E. Laurent
Biomolecules 2025, 15(1), 148; https://doi.org/10.3390/biom15010148
Full text available online: https://www.mdpi.com/2218-273X/15/1/148
7. “Integrins in Cardiovascular Health and Disease: Molecular Mechanisms and Therapeutic Opportunities”
by Karolina Ławkowska, Klaudia Bonowicz, Dominika Jerka, Yidong Bai and Maciej Gagat
Biomolecules 2025, 15(2), 233; https://doi.org/10.3390/biom15020233
Full text available online: https://www.mdpi.com/2218-273X/15/2/233
8. “Aromatic Characterisation of Moscato Giallo by GC-MS/MS and Validation of Stable Isotopic Ratio Analysis of the Major Volatile Compounds”
by Mauro Paolini, Alberto Roncone, Lorenzo Cucinotta, Danilo Sciarrone, Luigi Mondello, Federica Camin, Sergio Moser, Roberto Larcher and Luana Bontempo
Biomolecules 2024, 14(6), 710; https://doi.org/10.3390/biom14060710
Full text available online: https://www.mdpi.com/2218-273X/14/6/710
9. “Investigating the Suitability of Mare’s Milk-Derived Exosomes as Potential Drug Carriers”
by Shynggys Sergazy, Sanzhar Zhetkenev, Zarina Shulgau, Laura Chulenbayeva, Yevgeniy Kamyshanskiy, Madiyar Nurgaziyev, Ayaulym Nurgozhina, Zhanel Mukhanbetzhanova, Kulzhan Berikkhanova, Alexander Gulyayev et al.
Biomolecules 2024, 14(10), 1247; https://doi.org/10.3390/biom14101247
Full text available online: https://www.mdpi.com/2218-273X/14/10/1247
10. “Mitochondrial Dysfunction in Glycogen Storage Disorders (GSDs)”
by Kumudesh Mishra and Or Kakhlon
Biomolecules 2024, 14(9), 1096; https://doi.org/10.3390/biom14091096
Full text available online: https://www.mdpi.com/2218-273X/14/9/1096
13 August 2025
Meet Us at the 34th Annual Conference of the European Society for Biomaterials, 7–11 September 2025, Turin, Italy

MDPI is excited to announce its participation as an exhibitor at the 34th Annual Conference of the European Society for Biomaterials, taking place in Turin, Italy, from 7 to 11 September 2025.
The motto of the ESB 2025 conference is “Biomaterials on the horizon”. The horizon opens our mind to new and at times unexpected discoveries and reminds us of the charming challenges of our research. The motto is inspired by the fast development of new sources for multifunctional materials, and groundbreaking technologies that enable new structures and devices that improve healthcare, prevent pathologies, and allow patient-oriented therapies.
With all this in mind, in an exciting and dynamic environment, participants to ESB 2025 will share and discuss traditional areas of research, such as clinical translation, regenerative medicine, in vitro models, drug delivery, and antibacterial treatments, but also emerging themes, such as biomaterial-assisted gene and cell therapy, investigations at the (bio)molecular and cell scale, as well as crosscutting topics, such as artificial intelligence in biomaterial research, ethics, the 3Rs principle, and regulatory frameworks. Particular attention will be given to the Sustainable Development Goals, in which the role of the biomaterials is increasingly relevant.
The following MDPI journals will be presented at the conference:
- Bioengineering;
- International Journal of Molecular Sciences;
- Journal of Functional Biomaterials;
- Current Issues in Molecular Biology;
- Pharmaceutics;
- Biomimetics;
- Biomedicines;
- Biomolecules;
- Prosthesis;
- Materials;
- J — Multidisciplinary Scientific Journal;
- Journal of Pharmaceutical and BioTech Industry;
- Marine Drugs;
- Nanomaterials.
If you are attending this conference, please feel free to get in contact with us. Our delegates look forward to meeting you in person at booth #21 and answering any questions that you may have. For more information about the conference, please visit the following link: https://esb2025.org/.
31 July 2025
MDPI INSIGHTS: The CEO's Letter #25 - 8,000 Staff Worldwide, Korea Visit, 100,000 Preprints, Malaysia Roundtable, Canada Consortium Deal

Welcome to the MDPI Insights: The CEO's Letter.
In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.
Opening Thoughts
Talent Drives Our Progress
For the first time in MDPI’s history, we now have over 8,000 colleagues across the company. I would like to take a moment to celebrate this milestone and acknowledge the driving force behind our growth and success: our people.
As the world’s leading fully open access publisher, MDPI has grown thanks to the dedication, talent, and teamwork of colleagues across the company. Already halfway through 2025, we’ve welcomed nearly 2,000 new colleagues.
“Our achievements are also about the people behind them”
We now manage over 475 journals, with 298 receiving an Impact Factor, and hundreds more indexed in major databases, including 343 in Scopus, and 92 by PubMed. As the reach and impact of our journals continues to grow, so does the need for dedicated and qualified teams to support that growth. Thus, attracting and retaining exceptional talent remains a cornerstone of our success.
Our achievements are not just about the results of journal expansion, however: they’re about the people behind them. From our hardworking editors to our meticulous English editing and production teams – from our journal relationship specialists, public relations, marketing and communications professionals to our conference teams and the project teams behind Preprints, Scilit, SciProfiles, JAMS and more. Our success reflects the work of thousands of people showing up each day, taking pride in their work, and committed to excellence and service.
What we’re doing to support talent:
- Investing in onboarding and training to help new colleagues feel welcomed and empowered to thrive.
- Creating clearer career paths across all functions, from editorial to communications and beyond.
- Launching mentorship programs and internal knowledge-sharing sessions to promote growth and collaboration.
- Evolving our recognition and rewards programs to better celebrate your contributions.
- Expanding our training systems and platforms.
MDPI’s in-house training department offers over 215 training courses, covering topics from editorial development to cross-cultural collaboration. In 2024 alone, we had 44 full-time trainers and 196 part-time training assistants supporting the learning and development needs of colleagues worldwide. These efforts ensure our teams are equipped with the skills and confidence to grow professionally and contribute meaningfully.
Over two-thirds of our workforce is editorial, and of our more than 5,400 editors, 87% hold a Master’s degree and 6% a PhD. Their collective contributions are central to delivering a high-quality publishing experience and supporting global academic communication.
As we celebrate this milestone, we also aim to continue on a path of steady and sustainable growth, one that balances journal expansion with investment in people, outreach, processes, and innovation. Together, we are shaping the future of open access and academic publishing. Thank you for your hard work, your ideas, and your commitment to serving the global research community.
Let’s continue working together to create a culture where great talent grows and every colleague feels valued.
Impactful Research
Visiting South Korea: Building Connections and Supporting the MDPI Seoul Office
In July, I had the opportunity to visit our team in Seoul and engage directly with academic communities in South Korea. The visit focused on deepening MDPI’s relationships with local universities, institutions, and partners, and supporting the great work of our colleagues at the MDPI Seoul office.
Korea Association of Private University Libraries (KAPUL) Conference
A highlight of the visit was our participation in the Korea Association of Private University Libraries (KAPUL) Conference, where we presented to over 100 academic librarians. I delivered a keynote speech titled “The Evolving Publishing Landscape: Open Access and Beyond,” while my colleague Dr. Jisuk Kang (Public Affairs Specialist) shared insights in her presentation, “Inside MDPI: Editorial Practices & Research Integrity.”
Our participation received media coverage, including:
NEWS1: “Publishing Open Access Papers' MDPI...Supporting the Expansion of Korean Research Influence”
UNN (University News Network): “MDPI Announces ‘Seoul Declaration’... “Presenting Standards for Authenticity and Transparency in Korea”
Beyond Post: MDPI CEO Visits Korea to 'Support for the Development of Domestic Knowledge Ecosystem'
Facts & Figures: South Korea
- South Korea is MDPI’s sixth-largest publishing country by article volume (over 90,000 MDPI papers published to date).
- In 2024, Korea ranked 16th globally by total publications, and 6th (among these top 20 countries) by citation impact.
- 52% of Korean publications in 2024 were OA – and 73% of those were Gold OA.
- MDPI published about 20% of all OA papers from Korea in 2024.
- Over 2,000 active Editorial Board Members from South Korea contribute to MDPI journals, with 11 Section Editors-in-Chief.
- We currently have 11 Institutional Open Access Program agreements and two society partnerships in Korea:
- Korean Society of Pharmaceutical Sciences and Technology (with MDPI journal Pharmaceutics)
- Korean Tribology Society (with MDPI journal Coatings)
MDPI Seoul Office and the First Korea Salon
Our Seoul office serves as a regional hub for marketing, communications, and community engagement. It continues to grow in size and influence, prioritizing supporting scholar visits, conference sponsorships, and outreach events such as the recent MDPI Korea Salon.
The inaugural Salon, themed “Exploring Research Trends in Medical Publishing, Ethics, and AI,” brought together over 20 scholars and Editorial Board members serving MDPI journals.
Thank you to our guest speakers including Professors Young-Joon Surh of Seoul National University, Kwang-Sig Lee of Korea University, and Jin-Won Noh of Yonsei University who presented on the landscape of medicine in South Korea and across the globe. The Salon also included presentations from MDPI colleagues on Open Access, ethics, and how the IOAP can support researchers in this field.
“Our Seoul office continues to grow in size and influence”
Looking Ahead
MDPI is already the leading OA publisher in South Korea, yet challenges and misconceptions around OA and APCs remain. Visits like this one, along with the ongoing efforts of our Seoul office, are important to building understanding, trust, and long-term relationships with the local academic community.
A big thank-you to our colleagues in Seoul for their warm hospitality, professionalism, and energy! Our new office is well situated, staffed, and ready to grow. This visit marked an important step forward in our continued mission to support global research communities and advance Open Science.
Inside MDPI
Preprints.org Reaches 100,000 Preprints: A Major Milestone for MDPI and Open Science
In case you missed it, Preprints.org recently surpassed 100,000 preprints posted. This is a major milestone for our platform and one worth celebrating.
Preprints are a key pillar of the Open Science movement, which promotes transparency, equity, and faster knowledge-sharing through initiatives such as Open Access, Open Data, Open Source, and Open Peer Review. The benefits of Open Science extend beyond researchers, as they support funders, educators, policymakers, and the public in advancing discovery and innovation.
What is behind the 100,000 preprints milestone?
Since its launch in 2016, Preprints.org has grown into one of the world’s leading preprint platforms, now ranked fifth globally by publication volume.
More than 350,000 researchers have contributed, helping shape this dynamic and collaborative space for sharing early-stage research across all disciplines.
Read the full announcement here:
https://www.mdpi.com/about/announcements/12202
“Preprints.org has grown into one of the world’s leading preprint platforms”
Some quick facts worth noting:
- About 56% of the preprints on Preprints.org are later published in peer-reviewed journals.
- The platform is now indexed in Web of Science (Preprint Citation Index), Europe PMC, and Crossref, helping improve visibility and trust in the preprints shared.
- Recent upgrades – including a revamped website, new features such as search subscriptions, curated reading lists, and community feedback tools (PREreview) – show our commitment to developing Preprints.org in line with researchers’ needs.
This growth and progress would not be possible without the dedication of the Preprints.org team, our Advisory Board members, screeners, and colleagues across MDPI who support the platform’s development. This milestone is a reminder of our shared mission: to accelerate scientific communication and build a more open, transparent, and inclusive research ecosystem.
I’m excited to see what’s ahead as we approach Preprints.org’s 10-year anniversary in 2026!
Coming Together for Science
Malaysia Media Roundtable: Educating on Open Access and MDPI’s Presence in Southeast Asia
At the end of June, I had the opportunity to participate in a strategic media roundtable in Kuala Lumpur, focused on raising awareness about the importance of Open Access (OA) and on MDPI’s growing presence in Southeast Asia.
We welcomed five Malaysian media outlets for an engaging private session that included presentations and open discussion.
I gave an overview of the benefits of Open Access, MDPI’s global developments, and our collaborations in Malaysia.
My colleague Yu Nwe Soe (Public Relations Specialist), presented on our editorial process, helping to clarify how MDPI supports authors and maintains research quality.
We were also joined by two local Editorial Board Members (EBMs) who offered first-hand insights into their experiences working with MDPI and how OA has shaped their publishing choices.
The discussion covered a range of questions from the press, from OA publishing models to editorial standards, and highlighted MDPI’s unique contribution to accelerating scientific communication in the region.
As the leading fully OA publisher, we see it as our responsibility to continue educating research communities and the broader public on the impact of OA, especially in emerging and high-growth academic markets.
Spotlight on Malaysia
Malaysia continues to rise as a regional research hub, with five universities ranked in the global top 200 and 11 subjects in the global top 50. In 2024, Malaysia ranked 2nd in Southeast Asia in total publication output, 10th in Asia, and 25th globally.
MDPI’s presence in Malaysia:
- Over 21,000 research articles published to date from Malaysian institutions
- More than 1,100 articles published in 2024 alone
- In the period 2020–2024, 54% of Malaysia’s total publications were OA
- 36 EBMs from Malaysia, across 27 MDPI journals
- Around 100 conferences sponsored in Malaysia in the past five years
- MDPI is hosting the 2nd International Conference on AI Sensors and Transducers in Kuala Lumpur (29 July- 3 August 2025)
Media Coverage & Editorial Voices
Following the roundtable, we saw positive coverage across several local outlets, with articles highlighting MDPI’s role in empowering Malaysian researchers. Notable pieces included:
- Open-Access Empowers Malaysia’s Research Future
- Empowering Malaysian Researchers to Meet the Nation’s Innovation Ambitions
- MDPI and empowering Malaysian researchers
Our local EBMs also shared their perspectives:
Prof. Denny Ng Kok Sum (Sunway University, EBM of MDPI journal Processes) and Prof. Lee (EBM of MDPI journal Bacteria) share their experiences with MDPI and the role Open Access plays in their publication decisions.
“We see it as our responsibility to continue educating research communities on the impact of OA”
“I didn’t want my work stuck behind a paywall.”
— Prof. Denny Ng Kok Sum, Sunway University, Processes Editorial Board Member
“Open Access opens doors for collaboration and visibility, especially in fast-developing regions like ours.”
— Prof. Lee, Bacteria Editorial Board Member
This roundtable marked another step in building trust, understanding, and collaboration in Southeast Asia. A big thank-you to the MDPI Malaysia team and all those who contributed to the event’s success.
Closing Thoughts
MDPI Signs First North American Agreement with Canadian Consortium
We are proud to announce a major milestone for MDPI Canada and an important step forward for OA in North America.
In July, our Toronto office finalized MDPI’s first North American consortium agreement with the Federal Science Libraries Network (FSLN). This is a significant achievement that strengthens our expansion in Canada and reinforces our global commitment to supporting Open Science.
This two-year agreement gives Canadian federal agencies access to MDPI’s IOAP, including discounted article processing charges for affiliated researchers across our portfolio of over 475 OA journals. It lowers barriers for Canadian scientists to share their work more openly and reach a global audience.
Ryan Siu, Institutional Partnerships Manager at MDPI.
“The Open Science landscape in Canada is rapidly evolving, with the Tri-Agency Open Access Policy set for renewal by the end of 2025. This reflects ongoing efforts to foster greater scientific transparency and accessibility at a national policy level,” says Ryan Siu, Institutional Partnerships Manager at MDPI.
“Our new agreement with FSLN represents our shared commitment to further these efforts and foster wider readership. By aligning with these initiatives, we make progress towards research that’s both inclusive and impactful, benefiting local and global communities alike.”
Participating FSLN institutions include:
- Agriculture and Agri-Food Canada
- Environment and Climate Change Canada
- Health Canada
- National Research Council Canada
- Natural Resources Canada
By partnering with some of Canada’s largest science-based agencies, we reaffirm our goal of advancing OA across continents. We look forward to developing our support for Canadian researchers and continuing to drive progress in Open Science across North America and beyond.
Chief Executive Officer
MDPI AG
29 July 2025
Meet Us at the 61st Annual Meeting European Association for the Study of Diabetes (EASD 2025), 15–19 September 2025, Vienna, Austria

Conference: 61st Annual Meeting European Association for the Study of Diabetes (EASD 2025)
Date: 15–19 September 2025
Location: Vienna, Austria
MDPI will be attending the 61st Annual Meeting European Association for the Study of Diabetes (EASD 2025), which will be held from 15 to 19 September 2025, as an exhibitor. We welcome researchers from diverse backgrounds to attend and share their latest ideas with us.
The EASD Annual Meeting is an excellent opportunity to stay up to date with recent developments in the diabetes field. The programme features groundbreaking basic research, cutting-edge clinical trial results and in-depth expert debates. We are pleased to attend the conference and also meet with colleagues from around the world and be part of the key discussions that will shape the future of diabetes research and care. Your participation will significantly contribute to the medical discourse and enhance the conference’s impact within the diabetes field.
The following open access journals will be represented at the conference:
- Biomedicines;
- Diabetology;
- JCM;
- Medicina;
- IJERPH;
- Obesities;
- Nutrients;
- Biomolecules;
- LabMed;
- Lipidology;
- Metabolites;
- Endocrines.
If you are planning to attend the above conference, please do not hesitate to start an online conversation with us. Our delegates look forward to meeting you in person at the booth and answering any questions that you may have. For more information about the conference, please visit the following website: https://www.easd.org/annual-meeting/easd-2025.html.